• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

2

CATEGORIES

  • 6
  • 3
  • 1
  • 1

PRICE

8
9
10
11

PUBLISHED

0
3
3
11

PRODUCT TYPE

9
2

Search "Accentia Biopharmaceuticals Inc-Deals & Alliances Report" returned 11 results.

PRODUCT TITLE
Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012 Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012

Accentia Biopharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Accentia Biopharmaceuticals, Inc. - Product Pipeline Review - 2012” provides...

September 2012
FROM

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

August 2014
FROM

Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic SWOT Analysis Review

Summary Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of...

January 2013
FROM

Accentia Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

August 2014
FROM
Accentia Biopharmaceuticals Inc-Detailed Product Pipeline Accentia Biopharmaceuticals Inc-Detailed Product Pipeline - Product Thumbnail Image

Accentia Biopharmaceuticals Inc-Detailed Product Pipeline

Accentia Biopharmaceuticals Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances...

March 2011
FROM
Respiratory Drugs - Global Strategic Business Report Respiratory Drugs - Global Strategic Business Report - Product Thumbnail Image

Respiratory Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Respiratory Drugs in US$ Million The major product segments analyzed are Asthma, Allergic Rhinitis, and COPD (Chronic Obstructive Pulmonary Disease) The...

July 2006
FROM

Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review

Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

September 2014
FROM
Biovest International, Inc. (BVTI) - Financial and Strategic SWOT Analysis Review Biovest International, Inc. (BVTI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Biovest International, Inc. (BVTI) - Financial and Strategic SWOT Analysis Review

Biovest International, Inc. (BVTI) - Financial and Strategic SWOT Analysis Review Summary Biovest International, Inc. (Biovest), formerly known as Cellex Biosciences, Inc., is a specialty biopharmaceutical...

March 2012
FROM
Helix BioMedix, Inc. (HXBM) - Financial and Strategic SWOT Analysis Review Helix BioMedix, Inc. (HXBM) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Helix BioMedix, Inc. (HXBM) - Financial and Strategic SWOT Analysis Review

Helix BioMedix, Inc. (HXBM) - Financial and Strategic SWOT Analysis Review Summary Helix BioMedix, Inc. (Helix) is a biopharmaceutical company. It is pricipally engaged in the development of short,...

August 2011
FROM

Multiple Sclerosis - Pipeline Review, H2 2011

Multiple Sclerosis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Multiple Sclerosis - Pipeline Review, H2 2011', provides an overview of the Multiple Sclerosis therapeutic pipeline....

September 2011
FROM
F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010 F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010

F. Hoffmann-La Roche Ltd. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “F. Hoffmann-La Roche Ltd. - Product Pipeline Review - Q4 2010” provides data on...

December 2010
FROM
Loading Indicator